Rare hereditary disease
MYH9 741-749 (HLA-A*02:01) VLMIKALEL
Product number: EP11369_1
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
Human MYH9 of peptide VLMIKALEL covering 741-749 and HLA-A*02:01 molecule. The peptide recognizes CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. VLMIKALEL is a linear peptidic epitope (epitope ID69649) studied as part of Myosin-9 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
TechData
| Sequence: | VLMIKALEL |
| Gene: | MYH9 |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Myosin-9 |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | Flow Cytometry |
| Indication: | Rare hereditary disease |
| Purity: | 95% HPLC-MS |